PortfoliosLab logoPortfoliosLab logo
PJP vs. XLVI
Performance
Return for Risk
Drawdowns
Volatility
Dividends

Performance

PJP vs. XLVI - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Invesco Dynamic Pharmaceuticals ETF (PJP) and State Street Health Care Select Sector SPDR Premium Income ETF (XLVI). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, PJP achieves a 2.90% return, which is significantly higher than XLVI's -0.67% return.


PJP

1D
1.20%
1M
1.29%
YTD
2.90%
6M
2.29%
1Y
34.73%
3Y*
13.31%
5Y*
7.62%
10Y*
6.15%

XLVI

1D
0.67%
1M
2.30%
YTD
-0.67%
6M
0.76%
1Y
3Y*
5Y*
10Y*
*Multi-year figures are annualized to reflect compound growth (CAGR)

PJP vs. XLVI - Yearly Performance Comparison


Correlation

The correlation between PJP and XLVI is 0.77, which is moderate. They share some common price drivers but move independently often enough to provide real diversification benefit when combined.


Correlation
Correlation (All Time)
Calculated using the full available price history since Jul 31, 2025

0.77

PJP vs. XLVI - Sectors Allocation Comparison


Sectors
PJP
XLVI

Healthcare

100.0%

-

Basic Materials

-

-

Communication Services

-

-

Consumer Cyclical

-

-

Consumer Defensive

-

-

Energy

-

-

Financial Services

-

100.6%

Industrials

-

-

Real Estate

-

-

Technology

-

-

Utilities

-

-

Healthcare

PJP
100.0%
XLVI

-

Basic Materials

PJP

-

XLVI

-

Communication Services

PJP

-

XLVI

-

Consumer Cyclical

PJP

-

XLVI

-

Consumer Defensive

PJP

-

XLVI

-

Energy

PJP

-

XLVI

-

Financial Services

PJP

-

XLVI
100.6%

Industrials

PJP

-

XLVI

-

Real Estate

PJP

-

XLVI

-

Technology

PJP

-

XLVI

-

Utilities

PJP

-

XLVI

-

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

PJP vs. XLVI — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

PJP
PJP Risk / Return Rank: 6464
Overall Rank
PJP Sharpe Ratio Rank: 6363
Sharpe Ratio Rank
PJP Sortino Ratio Rank: 6464
Sortino Ratio Rank
PJP Omega Ratio Rank: 5757
Omega Ratio Rank
PJP Calmar Ratio Rank: 7373
Calmar Ratio Rank
PJP Martin Ratio Rank: 6363
Martin Ratio Rank

XLVI
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

PJP vs. XLVI - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Invesco Dynamic Pharmaceuticals ETF (PJP) and State Street Health Care Select Sector SPDR Premium Income ETF (XLVI). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


PJPXLVIDifference
Sharpe ratioReturn per unit of total volatility

Sortino ratioReturn per unit of downside risk

Omega ratioGain probability vs. loss probability

1.36

Calmar ratioReturn relative to maximum drawdown

3.70

Martin ratioReturn relative to average drawdown

11.55

PJP vs. XLVI - Sharpe Ratio Comparison


Loading charts...

Sharpe Ratios by Period


PJPXLVIDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

2.13

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

0.47

Sharpe Ratio (10Y)

Calculated over the trailing 10-year period

0.34

Sharpe Ratio (All Time)

Calculated using the full available price history

0.59

1.33

-0.73

Drawdowns

PJP vs. XLVI - Drawdown Comparison

The maximum PJP drawdown since its inception was -37.06%, which is greater than XLVI's maximum drawdown of -8.14%. Use the drawdown chart below to compare losses from any high point for PJP and XLVI.


Loading charts...

Drawdown Indicators


PJPXLVIDifference

Max Drawdown

Largest peak-to-trough decline

-37.06%

-8.14%

-28.92%

Max Drawdown (1Y)

Largest decline over 1 year

-9.44%

Max Drawdown (3Y)

Largest decline over 3 years

-16.27%

Max Drawdown (5Y)

Largest decline over 5 years

-17.51%

Max Drawdown (10Y)

Largest decline over 10 years

-33.95%

Current Drawdown

Current decline from peak

-2.94%

-4.02%

+1.08%

Average Drawdown

Average peak-to-trough decline

-8.85%

-1.95%

-6.90%

Ulcer Index

Depth and duration of drawdowns from previous peaks

3.02%

Volatility

PJP vs. XLVI - Volatility Comparison


Loading charts...

Volatility by Period


PJPXLVIDifference

Volatility (1M)

Calculated over the trailing 1-month period

5.33%

Volatility (6M)

Calculated over the trailing 6-month period

12.02%

Volatility (1Y)

Calculated over the trailing 1-year period

16.38%

10.94%

+5.44%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

16.17%

10.94%

+5.23%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

18.39%

10.94%

+7.45%

PJP vs. XLVI - Expense Ratio Comparison

PJP has a 0.58% expense ratio, which is higher than XLVI's 0.35% expense ratio.


Dividends

PJP vs. XLVI - Dividend Comparison

PJP's dividend yield for the trailing twelve months is around 0.99%, less than XLVI's 11.53% yield.


PositionTTM20252024202320222021202020192018201720162015
PJP
Invesco Dynamic Pharmaceuticals ETF
0.99%0.98%0.97%1.01%0.95%0.81%0.75%0.77%1.12%0.65%0.91%5.49%
XLVI
State Street Health Care Select Sector SPDR Premium Income ETF
11.53%5.73%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%

Frequently Asked Questions


PJP and XLVI have a correlation of 0.77, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

On fees, XLVI is cheaper at 0.35% per year. The better choice depends on whether you care most about return, fees, risk, or income.

XLVI is cheaper with a 0.35% expense ratio, compared with 0.58% for PJP.

XLVI has the higher dividend yield at 11.53%, compared with 0.99% for PJP.

PJP is categorized as Health & Biotech Equities, while XLVI is Derivative Income. They also come from different issuers: Invesco and State Street. Their fees differ too: 0.58% for PJP and 0.35% for XLVI.

Portfolio Optimizer

Find the right allocation for PJP and XLVI

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer